Télécharger le supplément (250 p.) - KCE
Télécharger le supplément (250 p.) - KCE
Télécharger le supplément (250 p.) - KCE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>KCE</strong> Reports 85 S Médecine à l’acte/médecine au forfait – ANNEXES 39<br />
medicaments non remboursés (en tout ou en partie)<br />
Drugs of limited clinical value : topical NSAIDs (≤2,88 items / 100 PU / yr.) (8)<br />
Low rate of prescribing of topical non – steroidal anti-inflammatory drugs (19)<br />
Prescription of vitamin B-12 injections: 12 week intervals (8)<br />
Prescription of vitamin B-12 injections: blood count in the previous year (8)<br />
Prescription of vitamin B-12 injections: hydrocycobalamin (8)<br />
Rate of hypnosedative and anxiolytic prescribing per patient (11)<br />
Performance indicator : effective delivery of appropriate health care : volume of<br />
prescribing of benzodiazepines – ratio of antidepressants to benzodiazepines<br />
(14)<br />
Number of items per 1000 patients for cough suppressants and nasal<br />
decongestants in past year (18)<br />
Number of items for cough suppressants or nasal decongestants/patient (17)<br />
% of total NIC on compound analgesics: co-codamol 30/500 (codeine phosphate<br />
30 mg and paracetamol 500 mg); paracetamol 500 mg and dihydrocodeine 20<br />
mg (17)<br />
Low rate of prescribing of aspirin in children ( < 12 years) (19)<br />
Drugs of limited clinical value : cerebral and peripheral vasodilatators ( ≤<br />
0,6items/100PU/yr.) (8)<br />
Number of items for peripheral and cerebral vasodilatators /patient (17)<br />
Low rate of prescribing of cerebral and peripheral vasodilatators (19)<br />
% of total NIC on drugs of limited clinical value ( cf British National Formulary<br />
Code) : (17)<br />
antidiarrhoeals<br />
peripheral vasodilatators (excluding thymoxamine)<br />
cerebral vasodilatators<br />
cough preparations (excluding methadone and diamorphine)<br />
systemic and topical nasal decongestants<br />
appetite suppressants<br />
bitters and tonics<br />
topical antirheumatics<br />
anti-infective preparation (excluding mupirocin and<br />
chlorhexidine/neomycin)<br />
antiseptic lozenges (?pastil<strong>le</strong>s) and sprays<br />
topical circulatory preparations<br />
Ratio: low risk NSAID to medium and high risk NSAIDs (11)<br />
Percentage of NSAID items comprised by the practice’s top four NSAIDs in past<br />
year : higher is better (18)<br />
DDDs/STAR-PU for oral NSAIDs (17)<br />
Drug choice within a therapeutic group (as % of re<strong>le</strong>vant BNF section):diclofenac<br />
, ibuprofen, indomethicin, naproxen (>=80%) (8)
Change language